Thomas Francis 3rd Isett - Sep 8, 2022 Form 4 Insider Report for iBio, Inc. (IBIO)

Role
CEO and Executive Chairman, Director
Signature
/s/Thomas F. Isett
Stock symbol
IBIO
Transactions as of
Sep 8, 2022
Transactions value $
$0
Form type
4
Date filed
9/12/2022, 04:02 PM
Previous filing
Sep 27, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IBIO Stock Option (right to buy) Award $0 +2M $0.00 2M Sep 8, 2022 Common Stock 2M $0.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest ratably in equal monthly instalments over a 36-month period beginning on the date of the grant (September 8, 2022), subject to the conditions of the iBio, Inc. 2020 Omnibus Incentive Compensation Plan, as amended, and the related stock option grant agreement.